Sleep and Type 2 Diabetes: Why Sleep Quality Belongs in a Whole-Person Care Plan
When people talk about managing type 2 diabetes, the conversation usually turns to food, medications, physical activity, or glucose monitoring. Sleep is often left out—despite the fact that poor sleep can affect energy, mood, appetite, activity, and the ability to follow through on every other part of a care plan. A new study adds to […]
Sleep Apnea and the Root Cause Conversation
The data is now a year old, but it has not been absorbed. In June 2024, the New England Journal of Medicine published the SURMOUNT-OSA trial results: tirzepatide, the GLP-1/GIP drug sold as Mounjaro and Zepbound, reduced sleep apnea severity by roughly 50% in adults with obesity. The 52-week, placebo-controlled study showed reductions in the […]